Gene: KCNQ1
Official Full Name: potassium voltage-gated channel subfamily Q member 1provided by HGNC
Gene Summary: This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06071 | KCNQ1 Knockout cell line (HeLa) | Human | KCNQ1 | 1:3~1:6 | Negative | Online Inquiry |
KO06072 | KCNQ1 Knockout cell line (HCT 116) | Human | KCNQ1 | 1:2~1:4 | Negative | Online Inquiry |
KO06073 | KCNQ1 Knockout cell line (HEK293) | Human | KCNQ1 | 1:3~1:6 | Negative | Online Inquiry |
KCNQ1 Gene Knockout Cell Lines are genetically modified cell lines where the KCNQ1 gene has been disrupted or eliminated, creating a valuable model for studying the physiological and pathological roles of this gene in various biological contexts. KCNQ1 encodes a potassium channel that plays a critical role in generating the cardiac current responsible for repolarization in the heart, and it is essential for maintaining the electrical stability of cardiac cells. The knockout of this gene allows researchers to investigate the precise contributions of KCNQ1 to cellular ionic currents, cardiac function, and potential arrhythmogenic conditions.
These cell lines enable a myriad of functional assays, including electrophysiological studies, drug testing, and mechanistic investigations into the effects of KCNQ1 mutations. By providing a system where KCNQ1-mediated currents are absent or altered, these models facilitate the examination of compensatory mechanisms and the interactions with other ion channels, making them indispensable in cardiovascular research. Additionally, they serve as an important resource for pharmacological studies aimed at identifying novel therapeutic compounds that may target the KCNQ1 potassium channel.
One of the primary advantages of utilizing KCNQ1 Gene Knockout Cell Lines over traditional models is the precision and reproducibility they offer in elucidating gene function and drug interactions. Unlike whole-organism studies, these cell lines allow for controlled experiments that can minimize biological variability, leading to more consistent and interpretable results. Furthermore, the ease of manipulation and scalability of cell culture systems make them a practical choice for both basic research and drug discovery.
Researchers and clinicians will find value in KCNQ1 Gene Knockout Cell Lines as they enable the exploration of novel therapeutic avenues in treating cardiac arrhythmias and related disorders, ultimately paving the way for innovation in cardiology. Our company has a long-standing commitment to advancing genetic research tools, offering high-quality biological products that empower the scientific community to push the boundaries of current knowledge. We ensure that our products are rigorously validated, providing the reliability needed for groundbreaking research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.